FINANCIAL TRUST COMPANY INC ACCT. W23560001
For the Period 2/1/12 to 2/29/12
Note P indicates position adjusted for Pending Trade Activity.
Unrealized GainLoss is shown as "N A" in cases where we do not have appropriate cost information for all lax lots comprising the position. Please contact your J P Morgan team for additional
information.
Equity Detail
Adjusted Tax Cost Unrealized Est. Annual Inc
Price Quantity Value Original Cost Gaintoss Accrued Div. Yield
US Large Cap Equity
ARIAD PHARMACEUTICALS INC 14.35 18,535.000 237,277.25 251,475.52 (14,198.27)
04033A-10-0 ARIA
BIOGEN [DEC INC 116.47 2,095.000 244,004.65 250,454.95 (6,450.30)
09062X-10-3 BIIB
DB CONT BUFF EQ MS 08/07/12 86.52 1,003.000 000 865,200.00 1,000,000.00 (134,80000)
25% CONTIN BARRIER- 13%CPN
30% CAP
INITIAL LEVEL-07,15,11 MS 21 09
2515A1-A7-6
P FIRST REPUBLIC BANK SAN FRAN 29.99 000
33616C-I0-0 FRC
HSBC MARKET PLUS SPX 05/17/13 100.03 5,000,000.000 5,001,500.00 5,003,000.00 1,500.00
72% KO BARRIER- 0%CPN
,UNCAPPED
INITIAL LEVEL-02/14/12 SPX:1350.50
4042K1-X0-1
P ONEOK PARTNERS LP 58.20 0.00 4.19%
682613N-10-3 OKS
JP Morgan Account W23560001 Page 5 of 33 Consolidated Statement Page 8
Confidential Treatment Requested by JPMorgan JPM-SDNY-00015582
Chase
CONFIDENTIAL SDNY_GM_00284780
EFTA01492769